DENVER, Colo., 24 June, 2024 (247marketnews.com) – (Nasdaq:ALT) are discussed in this article.
Altimmune, Inc. Common Stock (ALT) has experienced a remarkable surge of 30.09%, reaching $7.700 in trading volume of 19.3M shares today, indicating robust bullish momentum from the previous session’s close at $6.410. Technical analysis points towards a potential continued uptrend, presenting an optimistic signal for investors eyeing ALT. Concurrently, a class action lawsuit has been initiated against Altimmune and specific officers, as disclosed by Pomerantz LLP in the United States District Court. Filed under 24-cv-01315 in the District of Maryland, Southern Division, this legal action pertains to securities acquired between December 1, 2023, and April 26, 2024. The lawsuit seeks damages for alleged violations of federal securities regulations, particularly Sections 10(b) and 20(a) of the Exchange Act and Rule 10b-5. This development underscores the significance of compliance and transparency in the financial sector. Investors are advised to closely monitor updates on this ongoing legal matter and its potential impact on Altimmune, Inc. Common Stock and its stakeholders. For detailed information on the class action lawsuit, interested parties can refer to reputable news sources for further insights.
About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.
24/7 Market News, Inc Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.
CONTACT:
24/7 Market News
Editor@247marketnews.com